Skip to main content
Clinical Trials/DRKS00009293
DRKS00009293
Completed
未知

Evaluation of the alteration of spiroergometric parameters for CAD-patients after recanalization of chronic occluded coronary arteries (CTO)

Helios ForschungszentrumHelios Research Center GmbH Berlin Deutschland0 sites50 target enrollmentOctober 2, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Total coronary occlusions
Sponsor
Helios ForschungszentrumHelios Research Center GmbH Berlin Deutschland
Enrollment
50
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 2, 2015
End Date
October 30, 2015
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Helios ForschungszentrumHelios Research Center GmbH Berlin Deutschland

Eligibility Criteria

Inclusion Criteria

  • diagnosis: atherosclerotic hearts disease with one ore more Chronic Total coronary occlusions
  • \-demonstration of a chronic occluded main vessel with clinical symptoms (angina pectoris, dyspnoea, cardiac insufficiency) independent from severity and length of disease
  • \- proof of vitality of the less perfused supply zone of the myocardium
  • \- for our study we only recruit patient with successful coronary vessel recanalization

Exclusion Criteria

  • \- refusal of the spiroergometry for several reasons (pre\-existing orthopedic, pulmonic, neurologic diseases) that make an adequate stress impossible
  • \- expected incompliance due to the target stress level, the optimum medical therapy or fulfilment of medical appointments
  • \- additional coronary interventions during the observation period
  • \-malignant diseases and other accompanying diseases which might lead to a reduced physical resilience for other reasons
  • \- participation in another clinical trial
  • \- all patients who did not get an optimum medical therapy
  • \- patient with newly\-discovered severe diseases
  • \- severe vitiums
  • \- pregnancy or lactation
  • \- existing addictive disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials